Product DescriptionVitamin D3 (or cholecalciferol) is a biologically active substance, a vitamin belonging to the group of fat-soluble. It has been proven that vitamin D regulates calcium-phosphorus metabolism, is necessary to enhance the absorption of calcium from the stomach and delivery to various tissues of the body, as well as the reabsorption of phosphorus in the renal tubules. A lack of vitamin D3 in the body can be due to insufficient exposure to the sun or a lack of vitamin D3 in food. With a deficiency of vitamin D3, the content of calcium and phosphates in the blood decreases. ScopeUltra-D Vitamin D3 25 mcg (1000 IU) is recommended for use: as a biologically active food supplement – an additional source of vitamin D. Composition 1 tablet contains: Cholecalciferol (vitamin D3) – 25 mcg (1000 IU). Auxiliary ingredients: sweetener xylitol (E967), sweetener sorbitol (E420), thickener hydroxypropyl cellulose (E463), anti-caking agent magnesium fatty acid salts, antioxidant alpha-tocopherol (E307), palm oil, modified starch carrier (E1450), sucrose, antioxidant ascorbate sodium (E301), anti-caking agent amorphous silicon dioxide (E551), raspberry flavor, peach flavor. Ultra-D Vitamin D3 25 mcg (1000 IU) is available as a 425 mg chewable tablet. Vitamin D3, or cholecalciferol, is a biologically active substance, a fat-soluble vitamin. It enters the human body with food, but its content in foods is low, and absorption is possible only in a healthy intestine. Most of the vitamin must be synthesized in the skin under the influence of ultraviolet radiation, but with sufficient time in the sun and sufficient intensity of UV radiation. According to epidemiological studies, more than 80% of the adult population in Russia has a lack or deficiency of vitamin D, and such deficiency is noted both in summer and winter. Only 3.5% of women in Russia have normal levels of vitamin D. The biological role of vitamin D is explained by the presence of specific receptors in more than 40 organs and tissues and the control of more than 200 genes. Classical effects are associated with the regulation of calcium-phosphorus metabolism: vitamin D increases the absorption of calcium and phosphorus in the intestine, increases their reabsorption by the kidneys, increases the mineralization and elasticity of bone tissue, normalizes neuromuscular transmission, prevents myopathy against the background of mineral metabolism disorders (manifested by muscle weakness , difficulty walking, maintaining balance, and a tendency to fall). Adequate vitamin D levels prevent rickets in children and osteomalacia (decreased bone strength) in adults. Non-classical (extra-osseous effects): Reproductive functions: Vitamin D may positively influence the production of sex hormones (estradiol and progesterone). Vitamin D deficiency is observed in 67-85% of women with polycystic ovary syndrome. At the same time, the restoration of the recommended concentrations of vitamin D in the blood of these women helps to correct metabolic disorders, improve the quality of the endometrium, and restore the menstrual cycle. In IVF programs, pregnancy occurs 1.5 times more often in women with adequate vitamin D levels. The likelihood of having a child after ART/IVF is significantly higher in women without vitamin D deficiency. Low vitamin D levels are associated with an increased risk of endometriosis. During menopause, the need for vitamin D increases due to an increased risk of osteoporosis. Pregnancy: During this period, vitamin D is especially significant for both mother and unborn child. Studies show that low vitamin D levels are associated with an increased risk of gestational diabetes, preterm birth, preeclampsia, and caesarean section. Hypovitaminosis D in the mother leads to rickets in children, including congenital rickets, an increased risk of intrauterine infection and impaired immune regulation. Children born to mothers with normal vitamin D levels are less likely to develop respiratory viral infections and bronchiolitis. Lactation: The period of breastfeeding is a time of increased need for vitamin D for the mother. Male fertility: Vitamin D deficiency in men can lead to the development of secondary hypogonadism (lack of sex hormones), a decrease in testosterone production, impaired spermogram parameters (a decrease in the total number of spermatozoa, the number of spermatozoa with normal morphology and a decrease in their motility and linear speed), as well as – to an increased risk of developing type II diabetes mellitus, which is a fact of the development of male infertility. Nervous system: participating in the production of neurotransmitters (substances that transmit impulses between neurons), vitamin D has a positive effect on cognitive functions, psycho-emotional sphere and performance, improves mood and helps fight stress. Immune system: immunomodulatory effect is associated with the activation of all parts of the immune system. Vitamin D stimulates the activity of immune system cells in the bone marrow and has anti-inflammatory properties. Metabolism: Normal levels of vitamin D contribute to the normalization of fat metabolism, have a positive effect on the course of the metabolic syndrome, reduce the level of total cholesterol, triglycerides and low-density lipids. Normalization of energy production in cells leads to an increase in vitality. Endocrine system: Vitamin D deficiency plays a role in insulin resistance and glucose tolerance. According to studies, against the background of vitamin D deficiency, the production of insulin by pancreatic cells decreases, the work of the parathyroid gland and adrenal glands is disrupted. Suggested Use For adults, 1/2 tablet 1 time per day with meals. The recommended daily dose (1/2 tablet) contains: Component Sod. in 1/2 tab. % of rivers. ur. day consumption* % of rec. day level. consumption for women** of childbearing age*, 2nd half 1st half of pregnancy lactating pregnancy Vitamin D3 12.5 mcg (500 IU) 250*** 125-250*** 100 100 its markings”; ** – MP 2.3.1.2432-08. Norms of physiological needs for energy and nutrients for various groups of the population of the Russian Federation. M., 2008; *** Does not exceed the upper permissible consumption level, Uniform sanitary-epidemiological and hygienic requirements for goods subject to sanitary-epidemiological supervision (control). Duration of admission: 2 weeks. Before use, it is recommended to consult a doctor. WarningDetermination of the daily dose and duration of vitamin D intake can be made by a doctor individually, depending on the results of laboratory tests and medical history, and may differ from those recommended in this package leaflet. Do not exceed the dose recommended by your doctor. Due to solubilization (interaction with saliva components), absorption of the vitamin from Ultra-D Vitamin D3 25 mcg (1000 IU) chewable tablets begins in the oral cavity. The mucous membrane of the oral cavity is richly supplied with blood, due to which vitamin D quickly enters the bloodstream. After ingestion, absorption of vitamin D continues in the small intestine through the formation of micelles (multilayer colloidal particles). The dual mechanism of absorption of cholecalciferol from a chewable tablet ensures a high rate of absorption and the achievement of an adequate level of vitamin D in the blood serum. The manifestation of side effects of vitamin D directly depends on the dose consumed; side effects are manifested in the case of a significant excess of the recommended doses. Symptoms of hypervitaminosis: increased calcium in the blood, nausea, vomiting, headache, muscle pain, palpitations, loss of appetite, thirst, weakness. Contains sweetener. Overuse may have a laxative effect. Nutritional value of 1 tablet: sugar alcohols – 0.4 g, energy value – 0.9 kcal (4.9 kJ). ContraindicationsIndividual intolerance to the components. Shelf life 3 years. Do not use after the expiry date stated on the packaging. Storage conditions Store in the original packaging in a dry place, out of the reach of children, at a temperature not exceeding 25°C. Release form Chewable tablets, 25 mcg (1000 IU). 30, 60, 90 or 120 chewable tablets in a plastic bottle with a plastic cap. Buy biologically active food supplement “Ultra-D Vitamin D3 25 mcg (1000 IU)” (“Ultra-D Vitamin D3 25 mkg (1000 IU)”) (425 mg chewable tablets) (Vitamin D3) to food “Ultra-D Vitamin D3 25 mcg (1000 IU)” (“Ultra-D Vitamin D3 25 mkg (1000 IU)”) (chewable tablets weighing 425 mg) (Vitamin D3) Ultra-D Vitamin D3 25 mcg (1000 IU) (425 mg chewable tablets) (Vitamin D3)
biologically active food supplement “Ultra-D Vitamin D3 25 mcg (1000 IU)” (“Ultra-D Vitamin D3 25 mkg (1000 IU)”) (425 mg chewable tablets) (Vitamin D3)
$54.00
SKU: 135251
Category: Vitamin D
The code | 135251 |
---|---|
Barcode | 6 432 100 051 974 |
Active substance | Vitamin D |
Manufacturer | "Pharmia OY", Kalliotie 2, FI-04360, Tuusula, Finland for "Orion Corporation", Finland |
Scope of application | Vitamins and dietary supplements |
Indications Applications | As a biologically active food supplement – an additional source of vitamin D |
Contraindications | Individual intolerance to the components of the product |
Use during pregnancy and lactation | Can be used |
Age category | 16+ |
Application Gender | Any |
Release Form | tablets |
Composition Means | 1 tablet contains: Cholecalciferol (vitamin D3) – 25 mcg (1000 IU) |
Importer | SOOO "Brititrade", 223021, Minsk district, Shchomyslitsky s / s, 18; Limited Liability Company "Vitvar", 210023, Vitebsk, Frunze Ave., 26, building 3 |
Reviews
There are no reviews yet.